Treatment

  • Shields et al described that conversion of iris nevi to melanoma is:
    • 3% at 5 years
    • 4% at 10 years
    • 11% at 20 years
  • Lesions can be surgically excised if they remain anterior to the iris.
  • Treatment with iodine radiotherapy can be indicated.
  • Enucleation is necessary if the tumor does not remain local.
  • Metastasis remains biggest risk.